Skip Nav

HIV/AIDS Clinical Trials

Home > Clinical Trials > Search Results
Español Text Size

Recruiting Status Legend

Studies Seeking Participants

Recruiting
Not yet recruiting
Available for expanded access

Studies Not Seeking Participants

Active, not recruiting
Completed
Terminated
Suspended
Withdrawn
Enrolling by invitation
Temporarily not available for expanded access
No longer available for expanded access
Approved for marketing

Clinical Trial Search Results

34 studies were found about ( dolutegravir OR GSK1349572 )

Phase IIa Dose-ranging Study of GSK1349572 in HIV-1 Infected Adults

Condition: Acquired Immunodeficiency Syndrome; HIV-1 Infection

NCT ID: NCT00708110

Completed

A Pilot Study Assessing the Integrase Inhibitor GSK1349572 in HIV-infected Persons With Virus Resistant to Raltegravir

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT00950859

Active, not recruiting

Safety of and Immune Response to GSK1349572 in HIV-1 Infected Infants, Children, and Adolescents

Condition: HIV Infections

NCT ID: NCT01302847

Recruiting(En español)

A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT00951015

Active, not recruiting

Study Assessing Dolutegravir in HIV-1 Infected Subjects With Virus Resistant to Raltegravir and/or Elivitegravir

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01568892

Active, not recruiting

A Study of the Pharmacokinetics and Antiviral Activity of Dolutegravir in the Central Nervous System in HIV-1 Infected ART-naive Subjects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01499199

Active, not recruiting

A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01328041

Active, not recruiting

Dolutegravir Compared to Darunavir/Ritonavir , Each in Combination With Dual Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in ART-naive Subjects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01449929

Active, not recruiting

A Trial Comparing GSK1349572 50mg Plus Abacavir/Lamivudine Once Daily to Atripla (Also Called The SINGLE Trial)

Condition: Infection, Human Immunodeficiency Virus I

NCT ID: NCT01263015

Active, not recruiting

GSK1349572 Relative Bioavailability Study

Condition: HIV Infections

NCT ID: NCT01098513

Completed

A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily

Condition: Infection, Human Immunodeficiency Virus I

NCT ID: NCT01227824

Active, not recruiting

Drug Interaction Study Between GSK1349572 and Tipranavir/Ritonavir in Healthy Volunteers

Condition: HIV Infections

NCT ID: NCT01068925

Completed

Methadone-Dolutegravir (DTG - GSK1349572) Drug Interaction Study.

Condition: Infections, Human Immunodeficiency Virus and Hepatitis

NCT ID: NCT01467518

Completed

A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01231516

Active, not recruiting

Dolutegravir Expanded Access Study

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01536873

Available

A Study to Investigate the Pharmacokinetics, Safety and Tolerability of GSK1349572 (Dolutegravir, DTG) in Healthy Japanese Subjects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01332565

Completed

Relative Bioavailability Study of a Pediatric Granule Formulation of Dolutegravir

Condition: Infections, Human Immunodeficiency Virus and Herpesviridae

NCT ID: NCT01382238

Completed

A Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 and Rilpivirine and Dolutegravir and Rilpivirine in Healthy Adult Subjects

Condition: Infections, Human Immunodeficiency Virus and Hepatitis

NCT ID: NCT01467531

Completed

A Drug Interaction Study Evaluating Plasma GSK2248761 and GSK1349572 Pharmacokinetics in Healthy Adult Subjects.

Condition: Human Immunodeficiency Virus I Infection

NCT ID: NCT01283100

Suspended

Drug Interaction Study Between Dolutegravir and an Oral Contraceptive Containing Norgestimate and Ethinylestradiol

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01498861

Completed

Dolutegravir Renal Impairment Study

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01353716

Completed

Drug Interaction Study Between Dolutegravir and Prednisone

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01425099

Completed

Relative Bioavailability Study of Two New Dolutegravir/Abacavir/Lamivudine Fixed Dose Combination Tablets

Condition: Healthy Subjects; Infection, Human Immunodeficiency Virus

NCT ID: NCT01366547

Completed

Phase 1, Open Label, Two Arm, Fixed Sequence Study to Evaluate the Effect of Rifampin and Rifabutin on GSK1349572 Pharmacokinetics in Healthy Male and Female Volunteers

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01231542

Completed

A Study to Evaluate the Effect of Boceprevir and Telaprevir on Dolutegravir Pharmacokinetics in Healthy Adult Subjects (ING115697).

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01563328

Completed

Evaluation of the Bioequivalence of a Combined Formulated Tablet

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01622790

Completed

GSK1349572 Drug Interaction Study With Protease Inhibitors

Condition: Healthy Subjects; Infection, Human Immunodeficiency Virus

NCT ID: NCT00774735

Completed

GSK1349572 Hepatic Impairment Study

Condition: Healthy Subjects; Hepatic Impairment; Infection, Human Immunodeficiency Virus

NCT ID: NCT01231529

Completed

A Study to Evaluate the Effects of Calcium Carbonate and Ferrous Fumarate on Pharmacokinetics of Dolutegravir in Healthy Adult Subjects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01762995

Recruiting

GSK1349572 Drug Interaction Study With Efavirenz

Condition: Infections, Human Immunodeficiency Virus and Herpesviridae; Healthy

NCT ID: NCT01098526

Completed

GSK1349572 Drug Interaction Study With Fosamprenavir/Ritonavir

Condition: Infections, Human Immunodeficiency Virus and Herpesviridae

NCT ID: NCT01209065

Completed

A Phase 1, Open Label, Placebo-Controlled Study to Evaluate the Effect of GSK1349572 on Iohexol and Para-Aminohippurate Clearance in Healthy Subjects

Condition: Infections, Human Immunodeficiency Virus and Tuberculosis

NCT ID: NCT01214993

Completed

GSK1349572 Proton Pump Inhibitor Drug Interaction and Supratherapeutic Dose Study

Condition: Healthy Volunteer

NCT ID: NCT00942136

Completed

GSK1349572 Exposure in Blood, Seminal Fluid, and Rectal Fluid and Tissue in Healthy Male Subjects

Condition: Healthy

NCT ID: NCT01459315

Active, not recruiting